首页> 美国卫生研究院文献>Biochemical Journal >Human plasma alpha-cysteine proteinase inhibitor. Purification by affinity chromatography characterization and isolation of an active fragment.
【2h】

Human plasma alpha-cysteine proteinase inhibitor. Purification by affinity chromatography characterization and isolation of an active fragment.

机译:人血浆α-半胱氨酸蛋白酶抑制剂。通过亲和色谱法纯化表征和分离活性片段。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human plasma alpha-cysteine proteinase inhibitor (alpha CPI) was purified by a two-stage method: affinity chromatography on S-carboxymethyl-papain-Sepharose, and high-resolution anion-exchange chromatography. The protein was obtained as a form of Mr about 64 000 and material of higher Mr (about 100 000). In sodium dodecyl sulphate/polyacrylamide-gel electrophoresis with reduction, both forms showed a major component of Mr 64 000. An antiserum was raised against alpha CPI, and 'rocket' immunoassays showed the mean concentration in sera from 19 individuals to be 35.9 mg/dl. Both low-Mr and high-Mr forms of alpha CPI were confirmed to be sialoglycoproteins by the decrease in electrophoretic mobility after treatment with neuraminidase. alpha CPI was shown immunologically to be distinct from antithrombin III and alpha 1-antichymotrypsin, two serine proteinase inhibitors from plasma with somewhat similar Mr values. alpha CPI was also distinct from cystatins A and B, the two intracellular low-Mr cysteine proteinase inhibitors from human liver. Complexes of alpha CPI with papain were detectable in immunoelectrophoresis, but dissociated to free enzyme and intact inhibitor in sodium dodecyl sulphate/polyacrylamide-gel electrophoresis. The stoichiometry of binding of papain was close to 1:1 for both low-Mr and high-Mr forms. alpha CPI was found to be a tight-binding inhibitor of papain and human cathepsins H and L (Ki 34 pM, 1.1 nM and 62 pM respectively). By contrast, inhibition of cathepsin B was much weaker, Ki being about 35 microM. Dipeptidyl peptidase I also was weakly inhibited. Digestion of alpha CPI with bromelain gave rise to an inhibitory fragment of Mr about 22 000, which was isolated.
机译:人血浆中的α-半胱氨酸蛋白酶抑制剂(αCPI)通过两步法纯化:S-羧甲基-木瓜蛋白酶-Sepharose上的亲和层析和高分辨率阴离子交换层析。获得的蛋白质形式为Mr约64 000,Mr较高的物质(约100 000)。在十二烷基硫酸钠/聚丙烯酰胺凝胶电泳中,还原后的两种形式均显示出64 000先生的主要成分。针对αCPI产生了抗血清,“火箭”免疫测定法显示19个人的血清平均浓度为35.9 mg / dl。通过神经氨酸酶处理后电泳迁移率的降低,低-Mr和高-Mr形式的CPI均被确认为唾液酸糖蛋白。免疫学上显示,αCPI与抗凝血酶III和α1-抗胰凝乳蛋白酶(血浆中的两种丝氨酸蛋白酶抑制剂,Mr值有些相似)不同。 αCPI也不同于人肝中两种细胞内低Mr半胱氨酸蛋白酶抑制剂胱抑素A和B。在免疫电泳中可检测到αCPI与木瓜蛋白酶的复合物,但在十二烷基硫酸钠/聚丙烯酰胺-凝胶电泳中可分解为游离酶和完整抑制剂。低Mr和高Mr形式的木瓜蛋白酶结合的化学计量均接近1:1。发现αCPI是木瓜蛋白酶和人组织蛋白酶H和L(Ki分别为34 pM,1.1 nM和62 pM)的紧密结合抑制剂。相比之下,组织蛋白酶B的抑制作用要弱得多,Ki约为35 microM。二肽基肽酶I也被弱抑制。用菠萝蛋白酶消化αCPI会产生约22000先生的抑制片段,该片段被分离出来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号